Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors. Its structural features enable selective binding in biological systems, making it valuable in the production of active pharmaceutical ingredients (APIs) for targeted therapies. The compound's stereochemistry plays a critical role in enhancing drug efficacy and metabolic stability. It is commonly employed in research and development for central nervous system (CNS) drugs and oncology-related medications.